Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) Institutional Ownership
CUSIP: 67079U306
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2026
Institutions Reporting
115
Shares (Excl. Options)
2,625,047
Price
$164.62
- Type / Class
- Equity / Common Stock, $0.001 par value
- Symbol
- NUTX on Nasdaq
- Shares outstanding
- 6,961,308
- Price per share
- $95.04
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 2,625,047
- Total reported value
- $432,092,050
- % of total 13F portfolios
- 0%
- Share change
- +216,885
- Value change
- +$38,177,558
- Number of holders
- 115
- Price from insider filings
- $95.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- NUTX - Nutex Health Inc. - Common Stock, $0.001 par value is tracked under CUSIP 67079U306.
- 115 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 115 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $432,092,050 to $2,281.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 67079U306?
CUSIP 67079U306 identifies NUTX - Nutex Health Inc. - Common Stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 67079U306:
Significant Owners of Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Pertento Partners LLP | 5.2% | +12% | $38,015,980 | +$3,945,181 | 361,988 | +12% | Pertento Partners LLP | 05 Mar 2026 |
As of 31 Dec 2025, 115 institutional investors reported holding 2,625,047 shares of Nutex Health Inc. - Common Stock, $0.001 par value (NUTX). This represents 38% of the company’s total 6,961,308 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Topline Capital Management, LLC | 9.7% | 675,494 | +21% | 10% | $111,199,822 |
| Pertento Partners LLP | 4.7% | 324,422 | +20% | 5.9% | $53,406,350 |
| BlackRock, Inc. | 4% | 281,553 | +7.3% | 0% | $46,349,254 |
| VANGUARD GROUP INC | 3.7% | 258,743 | +20% | 0% | $42,594,273 |
| AMERICAN CENTURY COMPANIES INC | 1.9% | 132,041 | +15% | 0.01% | $21,736,589 |
| STATE STREET CORP | 1.2% | 86,792 | +12% | 0% | $14,287,699 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 83,211 | +2.6% | 0% | $13,700,407 |
| MILLENNIUM MANAGEMENT LLC | 1.1% | 74,326 | -20% | 0.01% | $12,235,546 |
| MORGAN STANLEY | 0.83% | 57,640 | -52% | 0% | $9,488,696 |
| UBS Group AG | 0.79% | 55,025 | -20% | 0% | $9,058,215 |
| ONE PLUS ONE WEALTH MANAGEMENT, LLC | 0.58% | 40,441 | -0.86% | 3.1% | $6,657,397 |
| Pacer Advisors, Inc. | 0.48% | 33,289 | +4.3% | 0.01% | $5,480,035 |
| NORTHERN TRUST CORP | 0.41% | 28,396 | -5.2% | 0% | $4,674,549 |
| TRUIST FINANCIAL CORP | 0.35% | 24,419 | 0% | 0.01% | $4,019,856 |
| DRIVE WEALTH MANAGEMENT, LLC | 0.34% | 23,364 | +0% | 0.75% | $3,846,182 |
| SEGALL BRYANT & HAMILL, LLC | 0.33% | 22,898 | -1.2% | 0.05% | $3,769,469 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.3% | 21,000 | 0.84% | $3,457,020 | |
| Bank of New York Mellon Corp | 0.28% | 19,682 | +159% | 0% | $3,240,032 |
| GOLDMAN SACHS GROUP INC | 0.28% | 19,287 | -35% | 0% | $3,175,026 |
| Penserra Capital Management LLC | 0.24% | 16,851 | 0.03% | $2,774,000 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.24% | 16,398 | 0% | 0% | $2,699,439 |
| JPMORGAN CHASE & CO | 0.23% | 16,133 | +9.1% | 0% | $2,655,814 |
| DIMENSIONAL FUND ADVISORS LP | 0.23% | 16,045 | 0% | 0% | $2,648,424 |
| PRINCIPAL FINANCIAL GROUP INC | 0.21% | 14,753 | +58% | 0% | $2,428,638 |
| VICTORY CAPITAL MANAGEMENT INC | 0.21% | 14,484 | -11% | 0% | $2,384,356 |
Institutional Holders of Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 24 | $2,281 | +$665 | $95.04 | 1 |
| 2025 Q4 | 2,625,047 | $432,092,050 | +$38,177,558 | $164.62 | 115 |
| 2025 Q3 | 2,410,337 | $249,039,597 | +$60,438,382 | $103.32 | 95 |
| 2025 Q2 | 1,744,372 | $217,157,205 | +$94,889,528 | $124.49 | 101 |
| 2025 Q1 | 1,013,754 | $47,676,848 | +$5,619,616 | $47.03 | 46 |
| 2024 Q4 | 906,750 | $28,734,542 | +$7,911,215 | $31.69 | 41 |
| 2024 Q3 | 464,248 | $10,285,872 | +$9,202,875 | $21.70 | 28 |
| 2024 Q2 | 21,223 | $12,625 | +$12,625 | $0.59 | 2 |